Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
University of Pittsburgh
Incyte Corporation
Iovance Biotherapeutics, Inc.
Xencor, Inc.
Incyte Corporation
Incyte Corporation
Lytix Biopharma AS
Threshold Pharmaceuticals